Skip to main content
. 2018 May 9;22(3):186–192. doi: 10.1016/j.bjid.2018.04.003

Fig. 1.

Fig. 1

Sustained virological response rates (SVR) for treatment with (A) sofosbuvir and daclatasvir; and (B) sofosbuvir and simeprevir: overall results, and rates according to clinical characteristics. Abbreviations: GT, genotype; RBV, ribavirin.